Noonan/Russo will operate as an independent unit within Havas Advertising’s Diversified Agencies Group. The group consists of over 50 independent agencies specializing in corporate communications, marketing, public relations, crisis management, financial and investor relations, interactivity, design and human resources. Noonan/Russo will report directly to Patrick Lemarchand, Chairman and CEO of Havas Advertising Diversified Agencies Group North America.
Since 1988, Noonan/Russo Communications has provided investor relations, public relations, corporate and marketing communications to leading international medical companies from its New York, San Francisco and London offices.
Commenting on the acquisition, Alain de Pouzilhac, Chairman and CEO of Havas Advertising, stated:We are delighted to have struck this agreement with Noonan/Russo which strengthens Havas Advertising’s expertise in the rapidly growing health care communications market. They are the leading agency in biotech, a market that continues to expand. Our combined capacities will enable us to develop our resources in a sector which is totally strategic for Havas Advertising.
Jean-Michel Carlo, Vice-Chairman of Havas Advertising, Chairman and CEO of Diversified Agencies Group Worldwide, added: Joining forces with Noonan/Russo Communications, a leader in its field, confirms our commitment to broadening our capabilities with high quality firms in North America.
